Celecoxib coupled to dextran via a glutamic acid linker yields a polymeric prodrug suitable for colonic delivery

Celecoxib, a selective cyclooxygenase-2 inhibitor, is potentially useful for the treatment of colonic diseases such as colorectal cancer and colitis. However, the cardiovascular toxicity of celecoxib limits its routine use in the clinic. Generally, colon-specific delivery of a drug both increases th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yonghyun, Kim, Jungyun, Kim, Wooseong, Nam, Joon, Jeong, Seongkeun, Lee, Sunyoung, Yoo, Jin-Wook, Kim, Min-Soo, Jung, Yunjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524528/
https://www.ncbi.nlm.nih.gov/pubmed/26251576
http://dx.doi.org/10.2147/DDDT.S89077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524528/
https://www.ncbi.nlm.nih.gov/pubmed/26251576
http://dx.doi.org/10.2147/DDDT.S89077

Ejemplares similares